• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,470.11 -238.41
( -0.31%)
Global Indices
Nasdaq
51,860.73 -306.69
(-0.59%)
Dow Jones
7,464.20 -14.49
(-0.19%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,542.79 -57.58
(-0.54%)
Forex
USD-INR
96.42 0.06
(0.07%)
EUR-INR
110.27 -0.10
(-0.09%)
GBP-INR
129.65 -0.46
(-0.35%)
JPY-INR
0.59 0.00
(-0.05%)

EQUITY - MARKET SCREENER

Indian Infotech and Software Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
509051
INE300B01022
1.8493596
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
59
99.67
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter
May 26,2026
Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales18.3411.27 63 52.7137.66 40
OPM %12.3211.62 -14.107.33 -
PBDT2.271.55 46 8.133.46 135
PBT2.021.30 55 7.122.72 162
NP1.301.05 24 4.502.11 113